Daruka Mahadevan

Search results

• University of Texas: Mays Cancer Center Receives Five-Year NCI-Designated Cancer Center Renewal

  Patrick M Sung, Mark Bonnen, Daruka Mahadevan & Ruben Mesa

  8/18/20

  1 item of Media coverage

  Press/Media: Press / Media

• Cancer Drugs Cause Large Cells that Resist Treatment; Scientist Aims to Stop It

  Daruka Mahadevan

  6/1/20

  1 item of Media coverage

  Press/Media: Press / Media

• Scientist explore potential drugs to prevent cell resistance in different types of cancer

  Daruka Mahadevan

  5/29/20

  1 item of Media coverage

  Press/Media: Press / Media

• University of Texas: Cancer Drugs Cause Large Cells That Resist Treatment

  Daruka Mahadevan

  5/29/20

  1 item of Media coverage

  Press/Media: Press / Media

• Cancer drugs cause large cells that resist treatment; scientist aims to stop it

  Daruka Mahadevan

  5/28/20

  3 items of Media coverage

  Press/Media: Press / Media

• Division Of Hematology Fda

  Daruka Mahadevan

  10/8/19

  1 item of Media coverage

  Press/Media: Press / Media

• New division chief named for hematology/medical oncology

  Anand B Karnad, Daruka Mahadevan & Ruben Mesa

  8/20/19

  1 item of Media coverage

  Press/Media: Press / Media

• Arizona startup will commercialize blood test for most major cancers

  Daruka Mahadevan

  5/26/19

  1 item of Media coverage

  Press/Media: Press / Media

• Copyright 2019 CNN Researchers look to bring new blood tests for cancer to market

  Daruka Mahadevan

  5/26/19

  1 item of Media coverage

  Press/Media: Press / Media

• Researchers look to bring new blood tests for cancer to market

  Daruka Mahadevan

  5/26/19

  5 items of Media coverage

  Press/Media: Press / Media

• UA researchers look to bring new blood tests for cancer to market

  Daruka Mahadevan

  5/25/19 → 5/26/19

  4 items of Media coverage

  Press/Media: Press / Media

• AZ researchers look to bring new blood tests for cancer to market

  Daruka Mahadevan

  5/25/19

  1 item of Media coverage

  Press/Media: Press / Media

• UA looks to bring cancer-detecting blood test to market

  Daruka Mahadevan

  5/25/19

  2 items of Media coverage

  Press/Media: Press / Media

• Startup to commercialize blood test for most major cancers

  Daruka Mahadevan

  5/23/19

  1 item of Media coverage

  Press/Media: Press / Media

• Startup to Commercialize Blood Test for Most Major Cancers

  Daruka Mahadevan

  5/23/19

  1 item of Media coverage

  Press/Media: Press / Media

• STARTUP TO COMMERCIALIZE BLOOD TEST FOR MOST MAJOR CANCERS

  Daruka Mahadevan

  5/21/19

  1 item of Media coverage

  Press/Media: Press / Media

• UA Team Uncovers Promising Lead in Genetic Approach to Treating Glioblastoma

  Daruka Mahadevan

  12/18/18

  1 item of Media coverage

  Press/Media: Press / Media

• UA TEAM UNCOVERS PROMISING LEAD IN GENETIC APPROACH TO TREATING GLIOBLASTOMA

  Daruka Mahadevan

  12/18/18

  1 item of Media coverage

  Press/Media: Press / Media

• UA team uncovers promising lead in genetic approach to treating glioblastoma

  Daruka Mahadevan

  11/29/18

  1 item of Media coverage

  Press/Media: Press / Media

• University of Arizona Team Uncovers Promising Lead in Genetic Approach to Treating Glioblastoma

  Daruka Mahadevan

  11/29/18

  1 item of Media coverage

  Press/Media: Press / Media

• Immunotherapy: Cancer's new frontier

  Daruka Mahadevan

  11/7/18

  1 item of Media coverage

  Press/Media: Press / Media

• An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

  Daruka Mahadevan

  10/2/18

  1 item of Media coverage

  Press/Media: Press / Media

• Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy

  Daruka Mahadevan

  10/2/18

  1 item of Media coverage

  Press/Media: Press / Media

• Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers

  Daruka Mahadevan

  10/2/18

  1 item of Media coverage

  Press/Media: Press / Media

• Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors; SPICE

  Daruka Mahadevan

  10/2/18

  1 item of Media coverage

  Press/Media: Press / Media